Value of Ischemia and Coronary Anatomy in Prognosis and Guiding Revascularization Among Patients With Stable Ischemic Heart Disease

被引:0
|
作者
Patel, Krishna K. [1 ]
Peri-Okonny, Poghni A. [2 ]
Giorgetti, Assuero [3 ]
Shaw, Leslee J. [1 ]
Gimelli, Alessia [3 ]
机构
[1] Icahn Sch Med Mt Sinai, Blavatnik Family Womens Hlth Res Inst, Zena & Michael A Weiner Cardiovasc Inst, Dept Med Cardiol & Populat Hlth Sci & Policy, 1425 Madison Ave,L2-33, New York, NY 10025 USA
[2] Yale Univ, Dept Med Cardiol, Sch Med, New Haven, CT USA
[3] Fdn Toscana Gabriele Monasterio, Dept Imaging, Pisa, Italy
基金
美国国家卫生研究院;
关键词
coronary artery disease; death; humans; myocardial perfusion imaging; risk factors; POSITRON-EMISSION-TOMOGRAPHY; ARTERY-DISEASE; RISK STRATIFICATION; CLINICAL-OUTCOMES; SURVIVAL BENEFIT; TERM SURVIVAL; PREDICTION; THERAPY; SURGERY; SCORE;
D O I
10.1161/CIRCIMAGING.123.016587
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The value of physiological ischemia versus anatomic severity of disease for prognosis and management of patients with stable coronary artery disease (CAD) is widely debated. METHODS: A total of 1764 patients who had rest-stress cadmium-zinc-telluride single-photon emission computed tomography myocardial perfusion imaging and angiography (invasive or computed tomography) were prospectively enrolled and followed for cardiac death/nonfatal myocardial infarction. The CAD prognostic index (CADPI) was used to quantify the extent and severity of angiographic disease. Prognostic value was assessed using Cox models, adjusted for pretest risk, known CAD, stressor, left ventricular ejection fraction, %ischemia and infarct, CADPI, and early (90-day) revascularization. Incremental prognostic value was evaluated using net reclassification index. RESULTS: The mean age was 69.7 +/- 9.5 years, 24.4% were women, and 29.3% had known CAD. Significant ischemia (>10%) was present in 28.4%. Nonobstructive, single, and multivessel disease was present in 256 (14.5%), 772 (43.8%), and 736 (41.7%), respectively. Early revascularization occurred in 579 (32.8%). Cardiac death/myocardial infarction occurred in 148 (8.4%) over a 4.6-year median follow-up. Both %ischemia and CADPI provided independent and incremental prognostic value over pretest clinical risk (P<0.001). In a model containing both ischemia and anatomy, ischemia was prognostic (hazard ratio per 5% up arrow, 1.35 [95% CI, 1.11-1.63]; P=0.002) but CADPI was not (hazard ratio per 10-unit up arrow, 1.09 [95% CI, 0.99-1.20]; P=0.07). Early revascularization modified the risk associated with %ischemia (interaction P=0.003) but not with CADPI (interaction P=0.6). %Ischemia and single-photon emission computed tomography variables added incremental prognostic value over clinical risk and CADPI (net reclassification index, 20.3% [95% CI, 9%-32%]; P<0.05); however, CADPI was not incrementally prognostic beyond pretest risk, %ischemia, and single-photon emission computed tomography variables (net reclassification index, 3.1% [95% CI, -5% to 15%]; P=0.21). CONCLUSIONS: Ischemic burden provides independent and incremental prognostic value beyond CAD anatomy and identifies patients who benefit from early revascularization. The anatomic extent of disease has independent prognostic value over clinical risk factors but offers limited incremental benefit for prognosis and guiding revascularization beyond physiological severity (ischemia).
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Value of Ischemia in Prognosis and Guiding Revascularization Among Patients With Chronic Coronary Artery Disease
    Saraste, Antti
    Knuuti, Juhani
    CIRCULATION-CARDIOVASCULAR IMAGING, 2024, 17 (09)
  • [2] Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease
    Mehta, Puja K.
    Quesada, Odayme
    Al-Badri, Ahmed
    Fleg, Jerome L.
    Volgman, Annabelle Santos
    Pepine, Carl J.
    Merz, C. Noel Bairey
    Shaw, Leslee J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 348 : 1 - 8
  • [3] Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease
    Weintraub, William S.
    Hartigan, Pamela M.
    Mancini, G. B. John
    Teo, Koon K.
    Maron, David J.
    Spertus, John A.
    Chaitman, Bernard R.
    Shaw, Leslee J.
    Berman, Daniel
    Boden, William E.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2019, 12 (02):
  • [4] Revascularization for patients with diabetes mellitus and stable ischemic heart disease: an update
    Mancini, G. B. John
    Farkouh, Michael
    Verma, Subodh
    CURRENT OPINION IN CARDIOLOGY, 2017, 32 (05) : 608 - 616
  • [5] Coronary collaterals improve prognosis in patients with ischemic heart disease
    Regieli, Jakub J.
    Jukema, J. Wouter
    Nathoe, Hendrik M.
    Zwinderman, Aeilko H.
    Ng, Sunanto
    Grobbee, Diederick E.
    van der Graaf, Yolanda
    Doevendans, Pieter A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 132 (02) : 257 - 262
  • [6] Association between appropriateness of coronary revascularization and quality of life in patients with stable ischemic heart disease
    Wijeysundera, Harindra C.
    Qiu, Feng
    Fefer, Paul
    Bennell, Maria C.
    Austin, Peter C.
    Ko, Dennis T.
    BMC CARDIOVASCULAR DISORDERS, 2014, 14
  • [7] Reexamining the Efficacy and Value of Percutaneous Coronary Intervention for Patients With Stable Ischemic Heart Disease
    Weintraub, William S.
    Boden, William E.
    JAMA INTERNAL MEDICINE, 2016, 176 (08) : 1190 - 1194
  • [8] Long-Term Clinical Outcomes Following Revascularization in High-Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease
    Bainey, Kevin R.
    Alemayehu, Wendimagegn
    Welsh, Robert C.
    Kumar, Arnav
    King, Spencer B., III
    Kirtane, Ajay J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (01): : 1 - 12
  • [9] Moving from volume to value for revascularization in stable ischemic heart disease: A review
    Gibbons, Raymond J.
    Weintraub, William S.
    Brindis, Ralph G.
    AMERICAN HEART JOURNAL, 2018, 204 : 178 - 185
  • [10] The effect of coronary revascularization treatment timing on mortality in patients with stable ischemic heart disease in British Columbia
    Hardiman, Sean
    Fradet, Guy
    Kuramoto, Lisa
    Law, Michael
    Robinson, Simon
    Sobolev, Boris
    PLOS ONE, 2024, 19 (10):